Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × tucatinib × CNS × Clear all

Phase

Status

Withdrawn 1 Unknown 1 Terminated 1 Recruiting 1 No longer available 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 7 Gastrointestinal 3 CNS 1

Conditions

Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Temozolomide 55 Radiotherapy 32 Magnetic Resonance Spectroscopy 31 Radiosurgery 24 Specimen Handling 21 Cyclophosphamide 21 Nivolumab 20 pembrolizumab 17 Radiation 16 Carboplatin 12 Bevacizumab 12 Biopsy 11 Ipilimumab 10 Cisplatin 10 Vincristine 9 Irinotecan 9 trametinib 8 Immunoglobulin G 8 Etoposide 8 dinutuximab 7 X-Rays 7 Topotecan 7 Lomustine 7 Disulfides 7 AZD 6244 7 sargramostim 6 olaparib 6 atezolizumab 6 Granulocyte-Macrophage Colony-Stimulating Factor 6 CTLA-4 Antigen 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04538742 2025-12-08

DB-07

AstraZeneca

Phase 1/2 Active not recruiting

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡